Define the sources of persistent HIV production

$402,434U19FY2013AINIH

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Paper 35476994 Paper 31969707 Paper 31019052 Paper 30830886 Paper 30745362 Paper 30142171 Paper 30045057 Paper 30036365 Paper 29894387 Paper 29863499 Paper 29800728 Paper 29572809 Paper 29457784 Paper 29220353 Paper 29182633 Paper 29142136 Paper 29114395 Paper 29112956 Paper 29082287 Paper 28984168 Paper 28906277 Paper 28844864 Paper 28803740 Paper 28794047 Paper 28636433 Paper 28592548 Paper 28527342 Paper 28494238 Paper 28407485 Paper 28398774 Paper 28230655 Paper 28191361 Paper 28147284 Paper 28122027 Paper 28094770 Paper 27898737 Paper 27858912 Paper 27755112 Paper 27725635 Paper 27683060 Paper 27644592 Paper 27601222 Paper 27578849 Paper 27536983 Paper 27500724 Paper 27482437 Paper 27480951 Paper 27463679 Paper 27447446 Paper 27400264 Paper 27382129 Paper 27294875 Paper 27235396 Paper 27206407 Paper 27174704 Paper 27119115 Paper 26962940 Paper 26950420 Paper 26845514 Paper 26842469 Paper 26829625 Paper 26829623 Paper 26829622 Paper 26828202 Paper 26731470 Paper 26688545 Paper 26676780 Paper 26642901 Paper 26526767 Paper 26473478 Paper 26468749 Paper 26414177 Paper 26413868 Paper 26392489 Paper 26372270 Paper 26349853 Paper 26343910 Paper 26329395 Paper 26321639 Paper 26299251 Paper 26258524 Paper 26239974 Paper 26171776 Paper 26169416 Paper 26067822 Paper 26041287 Paper 25984721 Paper 25900325 Paper 25877551 Paper 25877550 Paper 25873391 Paper 25822022 Paper 25797064 Paper 25778749 Paper 25750070 Paper 25747663 Paper 25733502 Paper 25723173 Paper 25723172 Paper 25719800

Abstract

PROJECT SUMMARY (See instructions): This Collaboratory application focuses on the best understood reservoir for HIV-1, the latent reservoir in resting CD4+ T cells. Our goal is to find small molecule approaches for targeting this reservoir. However, HlV-1 may also persist in other reservoirs in patients on H/\ART. Therefore a comprehensive approach to HIV-1 eradication requires the identification of all stable reservoirs and the development of strategies to eliminate each one. To this end, our laboratory has been analyzing the trace levels of residual viremia (RV) that can be detected using specialized assays in patients on HAART who have

View original record on NIH RePORTER →